Financing repurposed drugs for rare diseases: a case study of Unravel Biosciences.
Orphanet J Rare Dis
; 18(1): 287, 2023 09 12.
Article
in En
| MEDLINE
| ID: mdl-37700316
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Commerce
/
Rare Diseases
Type of study:
Health_economic_evaluation
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Orphanet J Rare Dis
Journal subject:
MEDICINA
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: